Analysis of Screen-detected Lung Cancers' Genomic Traits
Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY
Prospective, observational cohort study of patients undergoing surgical resection for low dose CT (LDCT) screen-detected lung cancer (detected through the SUMMIT study- ClinicalTrials.gov Identifier: NCT03934866/ lung screening programmes), in which translational research is a fundamental aspect.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 77
Healthy Volunteers: f
View:
• Diagnosed with confirmed lung cancer or probable lung cancer via LDCT screening.
• Planned for, or completed primary surgical resection either for histologically confirmed lung cancer, or strongly suspected lung cancer.
• Able to provide written informed consent (or verbal informed consent for participants consenting to retrospective diagnostic samples and data collection only).
Locations
Other Locations
United Kingdom
St Bart's Hospital
RECRUITING
London
UCLH
RECRUITING
London
Contact Information
Primary
Laura Hughes
ctc.ascent@ucl.ac.uk
0207 679 9284
Time Frame
Start Date: 2020-08-10
Estimated Completion Date: 2026-03-30
Participants
Target number of participants: 526
Related Therapeutic Areas
Sponsors
Leads: University College, London